Jean Marc Herbert

1.3k total citations
33 papers, 1.1k citations indexed

About

Jean Marc Herbert is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jean Marc Herbert has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Hematology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jean Marc Herbert's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Platelet Disorders and Treatments (6 papers). Jean Marc Herbert is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Platelet Disorders and Treatments (6 papers). Jean Marc Herbert collaborates with scholars based in France, Belgium and United States. Jean Marc Herbert's co-authors include J.P. Maffrand, Pierre Savi, Paquita Nurden, Alan T. Nurden, E Heilmann, Claude Bihour, Philip Janiak, S Lévy-Toledano, A. Bernat and J C Lormeau and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Hepatology.

In The Last Decade

Jean Marc Herbert

33 papers receiving 1.0k citations

Peers

Jean Marc Herbert
A Ichikawa Japan
S L Hong United States
Junji Yamanishi Japan
Zahida Qamri United States
Adriana Menichelli Italy
W K Pollock United Kingdom
Makoto Katori Japan
Kunie Eguchi United States
Irena Duka United States
James D. Eskra United States
A Ichikawa Japan
Jean Marc Herbert
Citations per year, relative to Jean Marc Herbert Jean Marc Herbert (= 1×) peers A Ichikawa

Countries citing papers authored by Jean Marc Herbert

Since Specialization
Citations

This map shows the geographic impact of Jean Marc Herbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Marc Herbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Marc Herbert more than expected).

Fields of papers citing papers by Jean Marc Herbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Marc Herbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Marc Herbert. The network helps show where Jean Marc Herbert may publish in the future.

Co-authorship network of co-authors of Jean Marc Herbert

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Marc Herbert. A scholar is included among the top collaborators of Jean Marc Herbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Marc Herbert. Jean Marc Herbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janiak, Philip, Bruno Poirier, Jean‐Pierre Bidouard, et al.. (2007). Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats. Kidney International. 72(11). 1345–1357. 107 indexed citations
2.
Gary‐Bobo, Magali, Philip Janiak, Pietro Marini, et al.. (2007). Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology. 46(1). 122–129. 243 indexed citations
3.
Dupuy, Évelyne, Bernard Job, Aı̈da Habib, et al.. (2003). Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP. British Journal of Haematology. 120(4). 633–642. 2 indexed citations
4.
Lambrechts, Diether, Erik Storkebaum, Lieve Moons, et al.. (2002). Deletion of the hypoxia-response element in the VEGF promoter causes adult onset motor neuron degeneration. 2 indexed citations
5.
Hainaud, Patricia, M. Bonneau, G Pignaud, et al.. (2001). The calcium inhibitor SR33805 reduces intimal formation following injury of the porcine carotid artery. Atherosclerosis. 154(2). 301–308. 4 indexed citations
6.
Schaeffer, Paul, et al.. (2000). Characterisation of the effects of SR146131, a novel non-peptide CCK1 receptor agonist, on IMR-32 human neuroblastoma cells. European Journal of Pharmacology. 397(2-3). 303–310. 4 indexed citations
7.
Herbert, Jean Marc & Peter Carmeliet. (1998). Urokinase mediates bFGF-induced vascular smooth muscle cell migration under the control of TGFβ. Fibrinolysis & proteolysis. 12(2). 89–96. 1 indexed citations
8.
Savi, Pierre, Paquita Nurden, Alan T. Nurden, S Lévy-Toledano, & Jean Marc Herbert. (1998). Clopidogrel: a review of its mechanism of action. Platelets. 9(3-4). 251–255. 94 indexed citations
9.
Lormeau, J C, et al.. (1997). DETERMINATION OF THE ANTI-FACTOR Xa ACTIVITY OF THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 AND OF TWO STRUCTURAL ANALOGUES. Thrombosis Research. 85(1). 67–75. 13 indexed citations
10.
Herbert, Jean Marc, Françoise Bono, Isabelle Lamarche, & Peter Carmeliet. (1997). THE INHIBITORY EFFECT OF HEPARIN FOR VASCULAR SMOOTH MUSCLE CELL PROLIFERATION OR MIGRATION IS NOT MEDIATED BY U-PA AND T-PA.. Thrombosis Research. 86(4). 317–324. 6 indexed citations
11.
Bernat, A., et al.. (1997). V2 Receptor Antagonism of DDAVP-Induced Release of Hemostasis Factors in Conscious Dogs. Journal of Pharmacology and Experimental Therapeutics. 282(2). 597–602. 37 indexed citations
12.
Yang, Li, Demetra Callas, Jean Marc Herbert, & Jawed Fareed. (1996). Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT2 antagonist (SR46349). Thrombosis Research. 81(5). 555–567. 7 indexed citations
13.
Lormeau, J C, et al.. (1996). Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.. PubMed. 76(1). 5–8. 22 indexed citations
14.
Bernat, A., et al.. (1995). Importance of platelet activating factor in anaphylaxis-induced t-PA and PAI-1 increase in the rabbit. Fibrinolysis and Proteolysis. 9(5). 316–318. 2 indexed citations
15.
Nurden, Paquita, Pierre Savi, E Heilmann, et al.. (1995). An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.. Journal of Clinical Investigation. 95(4). 1612–1622. 156 indexed citations
16.
Bernat, A., et al.. (1994). Low Doses of Endotoxin Potentiate Venous Thrombosis in the Rabbit. Pathophysiology of Haemostasis and Thrombosis. 24(4). 209–218. 6 indexed citations
17.
Schaeffer, Paul, et al.. (1994). CCK‐JMV‐180 acts as an antagonist of the CCKA receptor in the human IMR‐32 neuroblastoma cell line. FEBS Letters. 354(2). 203–206. 4 indexed citations
18.
Herbert, Jean Marc, et al.. (1992). Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen. European Journal of Pharmacology. 216(2). 175–181. 7 indexed citations
19.
Herbert, Jean Marc, G Valette, A. Bernat, et al.. (1992). SR 27417, a highly potent, selective and long-acting antagonist of the PAF receptor. Drugs of the Future. 17(11). 1011–1011. 6 indexed citations
20.
Herbert, Jean Marc, J.P. Maffrand, K. Taoubi, et al.. (1991). Verbascoside Isolated from Lantana camara, an Inhibitor of Protein Kinase C. Journal of Natural Products. 54(6). 1595–1600. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Ichikawa Breakdown of academic impact, for papers by S L Hong Breakdown of academic impact, for papers by Junji Yamanishi Breakdown of academic impact, for papers by Zahida Qamri Breakdown of academic impact, for papers by Adriana Menichelli Breakdown of academic impact, for papers by W K Pollock Breakdown of academic impact, for papers by Makoto Katori Breakdown of academic impact, for papers by Kunie Eguchi Breakdown of academic impact, for papers by Irena Duka Breakdown of academic impact, for papers by James D. Eskra
Rankless by CCL
2026